Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Economy

European Central Bank Follows Canada, Cuts Interest Rates to 3.75%

The European Central Bank (ECB) has reduced its main interest rate for the first time in five years, from a…

Read More »
Economy

Bank of Canada and European Central Bank Expected to Cut Interest Rates This Week

In a move that reflects both the domestic economic landscape and broader global trends, the Bank of Canada (BoC) is…

Read More »
Politics

Trump Found Guilty: Next Moves and 2024 Election Implications

A New York jury found former President Donald Trump guilty on 34 felony counts of falsifying business records to cover…

Read More »
Featured

Top 4 Reduced-Risk Nicotine Stocks to Watch in 2024

As the tobacco industry faces increasing regulatory scrutiny and changing consumer preferences, the major players are pivoting towards reduced-risk nicotine…

Read More »
Consumer

ELEVAI Skincare CEO to Present at Beauty Through Science Conference in Stockholm, Sweden

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…

Read More »
Politics

Trump Embraces Crypto Donations: A Potential Game Changer for Political Fundraising

In a groundbreaking move, Donald J. Trump’s 2024 presidential campaign has announced it will accept cryptocurrency donations, marking the first…

Read More »
Crypto

Ethereum ETFs Approved: A New Era for Cryptocurrency Investment

The recent approval by the U.S. Securities and Exchange Commission (SEC) of spot Ethereum exchange-traded funds (ETFs) marks a significant…

Read More »
Biotech

ELEVAI Biosciences CEO to Showcase Company’s Obesity and Muscle Loss Prevention Technology at UCLA LA-BEST 2024 Conference

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…

Read More »
Biotech

ELEVAI Labs Reports Q1 Earnings — Revenue Grows 330%

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…

Read More »
Featured

ELEVAI Labs: A Strategic Expansion in Biosciences and Skincare

ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…

Read More »
Back to top button